4//SEC Filing
Casdin Private Growth Equity Fund, L.P. 4
Accession 0000919574-24-000224
CIK 0001162194other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 8:51 PM ET
Size
23.1 KB
Accession
0000919574-24-000224
Insider Transaction Report
Form 4
Casdin Partners Master Fund, L.P.
Director10% Owner
Transactions
- Award
Common Stock
2024-01-05+11,246,525→ 11,246,525 total - Award
Common Stock
2024-01-05+2,744,219→ 2,744,219 total(indirect: See footnote)
Holdings
- 1,200,000(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]Received in exchange for 10,132,005 shares of common stock of SomaLogic, Inc. ("SomaLogic") pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated October 4, 2023, by and among Standard BioTools Inc. (the "Company"), Martis Merger Sub, Inc. and SomaLogic (the "Merger"). Per the terms of the Merger, each share of SomaLogic common stock was converted into the right to receive 1.11 shares of the Company's common stock (the "Exchange Ratio") at the effective time of the Merger (the "Effective Time"). The securities are owned directly by Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund ("Casdin"), (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the "GP"), and (iii) Eli Casdin, the managing member of Casdin and the GP.
- [F2]Received in exchange for 2,472,270 shares of common stock of SomaLogic pursuant to the Merger. Per the terms of the Merger, each share of SomaLogic common stock was converted pursuant to the Exchange Ratio at the Effective Time. The securities are owned directly by Casdin Private Growth Equity Fund, L.P. (the "Equity Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin, the investment adviser to the Equity Fund, and (ii) Eli Casdin, the managing member of Casdin.
- [F3]The securities are owned directly by Casdin Partners FO1-MSV, LP ("Casdin FO1") and may be deemed to be indirectly beneficially owned by (i) Casdin, the investment adviser to Casdin FO1, (ii) the GP, the general partner of Casdin FO1, and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC.
Documents
Issuer
STANDARD BIOTOOLS INC.
CIK 0001162194
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001823061
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 8:51 PM ET
- Size
- 23.1 KB